Learn More
Medchemexpress LLC (rac)-AR-13503 ((rac)-AR-13324 M1 metabolite) | 1254032-16-0 | 99.1% | 321.37 g/mol | C19H19N3O2 | 5MG

Supplier: Medchemexpress LLC HY1256395MG
(rac)-AR-13503 is a small-molecule ROCK/PKC inhibitor and an active metabolite of netarsudil. It inhibits angiogenesis, enhances retinal pigment epithelium (RPE) barrier function, and reduces aberrant neovascularization in preclinical models. The compound is provided as a high-purity research-grade solid for in vitro and in vivo studies.
- Inhibits ROCK and PKC signaling.
- Reduces angiogenesis and aberrant neovascularization in animal models.
- Enhances retinal pigment epithelium barrier function in dose-dependent assays.
- Active in vitro with HUVEC tube formation IC50 of approximately 21 nM.
- Provided as a high-purity research compound suitable for biological assays.
- Available in multiple small-mass package sizes for laboratory use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.